TIAA CREF Investment Management’s Fennec Pharmaceuticals FENC Stock Holding History
Bought
Maintained
Sold
Other funds holding FENC
6CM
OM
TIAA CREF Investment Management's FENC Position: Q1 2019 in Review
TIAA CREF Investment Management increased its Fennec Pharmaceuticals (FENC) stake by 19% in Q1 2019, buying an estimated $13.1K and bringing the position to 12,626 shares worth $61K. The position accounts for ﹤0.01% of the portfolio, ranked #2989.
TIAA CREF Investment Management first reported a position in FENC in Q2 2018 and has held it in 4 quarters since. The position peaked at $181K in Q2 2018. 49 funds tracked by Wall St. Rank hold FENC as of Q1 2019.
- TIAA CREF Investment Management held 12,626 shares of Fennec Pharmaceuticals worth $61K as of Q1 2019.
- TIAA CREF Investment Management bought 1,993 Fennec Pharmaceuticals shares in Q1 2019, an estimated $13.1K.
- Fennec Pharmaceuticals made up ﹤0.01% of TIAA CREF Investment Management's portfolio in Q1 2019, its #2989 holding.
- TIAA CREF Investment Management first reported a position in Fennec Pharmaceuticals in Q2 2018 and has held it in 4 quarters since.
- TIAA CREF Investment Management's Fennec Pharmaceuticals position peaked at $181K in Q2 2018.
- 49 funds tracked by Wall St. Rank held Fennec Pharmaceuticals as of Q1 2019.
Based on TIAA CREF Investment Management's 13F filing for Q1 2019, filed 14 May 2019.